Pelacarsen’s 2026 Trial: Pharma Resilience Tested
Pelacarsen's 2026 trial tests pharma resilience. See how drug development faces setbacks, why R&D investment matters, and what's next for Lp(a) therapies.
Pelacarsen's 2026 trial tests pharma resilience. See how drug development faces setbacks, why R&D investment matters, and what's next for Lp(a) therapies.
Will precision medicine deliver on heart health by 2026? See how AI and genomic sequencing are reshaping cardiovascular drug development.
AI now values properties, changing real estate investment. See how AI uses hyper-local data, cuts appraisal times by 30%, and impacts regulations.
Political risk claims will jump 15% by 2027. Insurers must adapt underwriting, reallocate capital, and offer new cyber warfare coverage.
What's next for North American jobs in 2026? See 5 key shifts affecting tech, manufacturing, and healthcare, and how remote work changes hiring.
Retailers, prepare for 2026. AI personalization isn't optional; it's survival. See how predictive intimacy boosts customer value by 20%.
Nearshoring investments surged 15% in 2 years. See why companies are moving production closer to home, driven by trade policy and new incentives.
Chile holds 20% of global copper. Can it be a nearshoring leader? See why companies are investing $18.6B and what to watch next.
AI cuts manufacturing downtime by 20% and improves quality. See how AI impacts production lines, inventory, and what's next for your business.
Latin America's nearshoring boom is driving $50B in projects by 2026. See how Mexico, Brazil, and Central America are impacted.